User profiles for Luisa F Duarte
 | Luisa F. DuartePostdoctoral Research Scientist - Pontificia Universidad Católica de Chile - UNAB Verified email at uc.cl Cited by 949 |
[HTML][HTML] Herpes simplex virus type 1 infection of the central nervous system: insights into proposed interrelationships with neurodegenerative disorders
LF Duarte, MA Farías, DM Álvarez… - Frontiers in Cellular …, 2019 - frontiersin.org
Herpes simplex virus type 1 (HSV-1) is highly prevalent in humans and can reach the brain
without evident clinical symptoms. Once in the central nervous system (CNS), the virus can …
without evident clinical symptoms. Once in the central nervous system (CNS), the virus can …
Safety and immunogenicity of an inactivated severe acute respiratory syndrome coronavirus 2 vaccine in a subgroup of healthy adults in Chile
Background The development of effective vaccines against coronavirus disease 2019 is a
global priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus 2 (…
global priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus 2 (…
Recognition of variants of concern by antibodies and T cells induced by a SARS-CoV-2 inactivated vaccine
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
responsible of the current pandemic ongoing all around the world. Since its discovery in 2019, …
responsible of the current pandemic ongoing all around the world. Since its discovery in 2019, …
Immune profile and clinical outcome of breakthrough cases after vaccination with an inactivated SARS-CoV-2 vaccine
Constant efforts to prevent infections by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
are actively carried out around the world. Several vaccines are currently …
are actively carried out around the world. Several vaccines are currently …
A booster dose of CoronaVac increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern
CoronaVac is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization
(WHO). Previous studies reported increased levels of neutralizing antibodies and specific …
(WHO). Previous studies reported increased levels of neutralizing antibodies and specific …
[HTML][HTML] Current antivirals and novel botanical molecules interfering with herpes simplex virus infection
DM Álvarez, E Castillo, LF Duarte, J Arriagada… - Frontiers in …, 2020 - frontiersin.org
Herpes simplex viruses type 1 (HSV-1) and type 2 (HSV-2) are highly prevalent within the
human population and are characterized by lifelong infections and sporadic recurrences due …
human population and are characterized by lifelong infections and sporadic recurrences due …
[HTML][HTML] Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial
Background The ongoing COVID-19 pandemic has had a significant impact worldwide, with
an incommensurable social and economic burden. The rapid development of safe and …
an incommensurable social and economic burden. The rapid development of safe and …
[HTML][HTML] Experimental dissection of the lytic replication cycles of herpes simplex viruses in vitro
…, N Corrales, LF Duarte… - Frontiers in …, 2018 - frontiersin.org
Herpes simplex viruses type 1 and type 2 (HSV-1 and HSV-2) produce lifelong infections
and are highly prevalent in the human population. Both viruses elicit numerous clinical …
and are highly prevalent in the human population. Both viruses elicit numerous clinical …
[HTML][HTML] Comparison of seven diagnostic tests to detect Trypanosoma cruzi infection in patients in chronic phase of Chagas disease
DUARTE, Luisa Fernanda; FLOREZ, Oscar; RINCON, Giovanna and GONZALEZ, Clara Isabel.
Comparison of seven diagnostic tests to detect Trypanosoma cruzi infection in patients in …
Comparison of seven diagnostic tests to detect Trypanosoma cruzi infection in patients in …
Inactivated vaccine-induced SARS-CoV-2 variant-specific immunity in children
…, A Piña-Iturbe, G Hoppe-Elsholz, LF Duarte… - Mbio, 2022 - Am Soc Microbiol
Multiple vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have been evaluated in clinical trials. However, trials addressing the immune response in the …
have been evaluated in clinical trials. However, trials addressing the immune response in the …
